title: Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
authors.forename: I
authors.initials: I
authors.lastname: Del Corso
authors.forename: I
authors.initials: I
authors.lastname: Puxeddu
authors.forename: E
authors.initials: E
authors.lastname: Sardano
authors.forename: S
authors.initials: S
authors.lastname: Geraci
authors.forename: M
authors.initials: M
authors.lastname: Breggia
authors.forename: V
authors.initials: V
authors.lastname: Rocchi
authors.forename: P
authors.initials: P
authors.lastname: Migliorini
mesh_terms: D000799:Angioedema / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D001920:Bradykinin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D065094:Bradykinin B2 Receptor Antagonists; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D043782:Receptor, Bradykinin B2 / Q000378:metabolism
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D065094:Bradykinin B2 Receptor Antagonists; D043782:Receptor, Bradykinin B2; C065679:icatibant; D001920:Bradykinin